During the last session, Inspire Medical Systems Inc (NYSE:INSP)’s traded shares were 0.31 million, with the beta value of the company hitting 1.37. At the end of the trading day, the stock’s price was $151.25, reflecting an intraday loss of -1.01% or -$1.54. The 52-week high for the INSP share is $225.00, that puts it down -48.76 from that peak though still a striking 18.68% gain since the share price plummeted to a 52-week low of $123.00. The company’s market capitalization is $4.46B, and the average trade volume was 520.15K shares over the past three months.
Inspire Medical Systems Inc (INSP) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.62. INSP has a Sell rating from 0 analyst(s) out of 8 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.21.
Inspire Medical Systems Inc (NYSE:INSP) trade information
Inspire Medical Systems Inc (INSP) registered a -1.01% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.01% in intraday trading to $151.25, hitting a weekly high. The stock’s 5-day price performance is -5.36%, and it has moved by -1.66% in 30 days. Based on these gigs, the overall price performance for the year is -38.42%.
The consensus price target of analysts on Wall Street is $207.5, which implies an increase of 27.11% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $200 and $215 respectively. As a result, INSP is trading at a discount of -42.15% off the target high and -32.23% off the low.
Inspire Medical Systems Inc (INSP) estimates and forecasts
In the rating firms’ projections, revenue will increase 18.23% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 214.5M as predicted by 16 analyst(s). Meanwhile, a consensus of 16 analyst(s) estimates revenue growth to 240.34M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 195.88M and 203.19M respectively. In this case, analysts expect current quarter sales to grow by 9.50% and then jump by 18.28% in the coming quarter.
While earnings are projected to return 29.54% in 2025, the next five years will return 35.59% per annum.
INSP Dividends
Inspire Medical Systems Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 2.87 million shares, is of VANGUARD GROUP INC’s that is approximately 9.6526% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $384.04 million.
Also, the Mutual Funds coming in first place with the largest holdings of Inspire Medical Systems Inc (INSP) shares are iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . Data provided on Mar 31, 2025 indicates that iShares Trust-iShares Core S&P Small-Cap ETF owns about 1.83 shares. This amounts to just over 6.22 percent of the company’s overall shares, with a $277.49 million market value. The same data shows that the other fund manager holds slightly less at 933.62, or about 3.17% of the stock, which is worth about $141.21 million.
